Company: BIAF
Filing Date: 2025-09-05
Form Type: 8-K
Source: 0001641172-25-026758
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-05
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item
7.01. Regulation FD Disclosure.

bioAffinity
Technologies, Inc., a Delaware corporation, (the “ Company”) has prepared presentation materials (the “ Presentation
Materials”) that management intends to use from time to time in presentations about the Company’s operations and performance,
including at the H. C. Wainwright 27thAnnual Global Investment Conference being held September 8, 2025 through September 10,
2025. The Presentation Materials are furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The
information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K are furnished and shall not be deemed to be “filed”
for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject
to the liabilities of that section. The information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K shall not be
incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after
the date of this Current Report, regardless of any general incorporation language in any such filing.